Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function
Summary: Hyperactivating mutations in the non-receptor tyrosine phosphatase SHP2 cause Noonan syndrome (NS). NS is associated with cognitive deficits, but how hyperactivation of SHP2 in NS changes neuron function is not well understood. We find that mice bearing an NS-associated SHP2 allele (NS mice...
| Main Authors: | , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2018-08-01
|
| Series: | Cell Reports |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S2211124718310830 |
| _version_ | 1798043187666747392 |
|---|---|
| author | Aaron D. Levy Xiao Xiao Juliana E. Shaw Suma Priya Sudarsana Devi Sara Marie Katrancha Anton M. Bennett Charles A. Greer James R. Howe Kazuya Machida Anthony J. Koleske |
| author_facet | Aaron D. Levy Xiao Xiao Juliana E. Shaw Suma Priya Sudarsana Devi Sara Marie Katrancha Anton M. Bennett Charles A. Greer James R. Howe Kazuya Machida Anthony J. Koleske |
| author_sort | Aaron D. Levy |
| collection | DOAJ |
| description | Summary: Hyperactivating mutations in the non-receptor tyrosine phosphatase SHP2 cause Noonan syndrome (NS). NS is associated with cognitive deficits, but how hyperactivation of SHP2 in NS changes neuron function is not well understood. We find that mice bearing an NS-associated SHP2 allele (NS mice) have selectively impaired Schaffer collateral-CA1 NMDA (N-methyl-D-aspartate) receptor (NMDAR)-mediated neurotransmission and that residual NMDAR-mediated currents decay faster in NS mice because of reduced contribution of GluN1:GluN2B diheteromers. Consistent with altered GluN2B function, we identify GluN2B Y1252 as an NS-associated SHP2 substrate both in vitro and in vivo. Mutation of Y1252 does not alter recombinant GluN1:GluN2B receptor kinetics. Instead, phospho-Y1252 binds the actin-regulatory adaptor protein Nck2, and this interaction is required for proper NMDAR function. These results establish SHP2 and Nck2 as NMDAR regulatory proteins and strongly suggest that NMDAR dysfunction contributes to NS cognitive deficits. : Noonan syndrome (NS) is caused by hyperactive SHP2 and is associated with cognitive deficits. Levy et al. find that NMDA receptor (NMDAR)-mediated currents are disrupted in NS and identify GluN2B Y1252 as a neural substrate of SHP2. Y1252 in turn binds the actin regulator Nck2 to control spine actin and regulate NMDAR currents. Keywords: Noonan syndrome, SHP2, NMDA receptor, GluN2B, tyrosine phosphorylation |
| first_indexed | 2024-04-11T22:46:00Z |
| format | Article |
| id | doaj.art-2fcf40d6c87c43689141ac463046f066 |
| institution | Directory Open Access Journal |
| issn | 2211-1247 |
| language | English |
| last_indexed | 2024-04-11T22:46:00Z |
| publishDate | 2018-08-01 |
| publisher | Elsevier |
| record_format | Article |
| series | Cell Reports |
| spelling | doaj.art-2fcf40d6c87c43689141ac463046f0662022-12-22T03:58:46ZengElsevierCell Reports2211-12472018-08-0124615231535Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor FunctionAaron D. Levy0Xiao Xiao1Juliana E. Shaw2Suma Priya Sudarsana Devi3Sara Marie Katrancha4Anton M. Bennett5Charles A. Greer6James R. Howe7Kazuya Machida8Anthony J. Koleske9Interdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USADepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USADepartment of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USADepartment of Pharmacology, Yale University, New Haven, CT 06520, USAInterdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USADepartment of Pharmacology, Yale University, New Haven, CT 06520, USA; Program in Integrative Cell Signaling and Neurobiology of Metabolism, Yale University, New Haven, CT 06520, USAInterdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USA; Department of Neurosurgery, Yale University, New Haven, CT 06520, USA; Department of Neuroscience, Yale University, New Haven, CT 06520, USAInterdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USA; Department of Pharmacology, Yale University, New Haven, CT 06520, USARaymond and Beverly Sackler Laboratory of Genetics and Molecular Medicine, Department of Genetics and Genome Sciences, University of Connecticut School of Medicine, Farmington, CT 06030, USAInterdepartmental Neuroscience Program, Yale University, New Haven, CT 06520, USA; Department of Molecular Biophysics and Biochemistry, Yale University, New Haven, CT 06520, USA; Department of Neuroscience, Yale University, New Haven, CT 06520, USA; Program in Cellular Neuroscience, Neurodegeneration and Repair, Yale University, New Haven, CT 06520, USA; Corresponding authorSummary: Hyperactivating mutations in the non-receptor tyrosine phosphatase SHP2 cause Noonan syndrome (NS). NS is associated with cognitive deficits, but how hyperactivation of SHP2 in NS changes neuron function is not well understood. We find that mice bearing an NS-associated SHP2 allele (NS mice) have selectively impaired Schaffer collateral-CA1 NMDA (N-methyl-D-aspartate) receptor (NMDAR)-mediated neurotransmission and that residual NMDAR-mediated currents decay faster in NS mice because of reduced contribution of GluN1:GluN2B diheteromers. Consistent with altered GluN2B function, we identify GluN2B Y1252 as an NS-associated SHP2 substrate both in vitro and in vivo. Mutation of Y1252 does not alter recombinant GluN1:GluN2B receptor kinetics. Instead, phospho-Y1252 binds the actin-regulatory adaptor protein Nck2, and this interaction is required for proper NMDAR function. These results establish SHP2 and Nck2 as NMDAR regulatory proteins and strongly suggest that NMDAR dysfunction contributes to NS cognitive deficits. : Noonan syndrome (NS) is caused by hyperactive SHP2 and is associated with cognitive deficits. Levy et al. find that NMDA receptor (NMDAR)-mediated currents are disrupted in NS and identify GluN2B Y1252 as a neural substrate of SHP2. Y1252 in turn binds the actin regulator Nck2 to control spine actin and regulate NMDAR currents. Keywords: Noonan syndrome, SHP2, NMDA receptor, GluN2B, tyrosine phosphorylationhttp://www.sciencedirect.com/science/article/pii/S2211124718310830 |
| spellingShingle | Aaron D. Levy Xiao Xiao Juliana E. Shaw Suma Priya Sudarsana Devi Sara Marie Katrancha Anton M. Bennett Charles A. Greer James R. Howe Kazuya Machida Anthony J. Koleske Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function Cell Reports |
| title | Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function |
| title_full | Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function |
| title_fullStr | Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function |
| title_full_unstemmed | Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function |
| title_short | Noonan Syndrome-Associated SHP2 Dephosphorylates GluN2B to Regulate NMDA Receptor Function |
| title_sort | noonan syndrome associated shp2 dephosphorylates glun2b to regulate nmda receptor function |
| url | http://www.sciencedirect.com/science/article/pii/S2211124718310830 |
| work_keys_str_mv | AT aarondlevy noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT xiaoxiao noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT julianaeshaw noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT sumapriyasudarsanadevi noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT saramariekatrancha noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT antonmbennett noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT charlesagreer noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT jamesrhowe noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT kazuyamachida noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction AT anthonyjkoleske noonansyndromeassociatedshp2dephosphorylatesglun2btoregulatenmdareceptorfunction |